A dominant negative mutant Friend murine leukemia virus (FMLV) env gene was cloned from an immunoselected Friend erythroleukemia cell. The mutant env had a point mutation which resulted in a Cys-to-Arg substitution at the 361st amino acid in the FMLV envelope protein (Env). The mutant Env was retained in the endoplasmic reticulum (ER) and accumulated because of its slow degradation. The NIH 3T3 cells expressing the mutant env were resistant to ecotropic Moloney MLV (MoMLV) penetration, suggesting that the mutant Env traps the ecotropic MLV receptors in the ER. When the mutant env gene was transfected into and expressed in the cells persistently infected with MoMLV, the wild-type Env was trapped in the ER, and the MoMLV production was suppressed. Thus, the mutant Env accumulating in the ER trans-dominantly and efficiently interfered with the ecotropic MLV infection at both the early and the late stages.
The retroviral env gene product (Env) is processed in the endoplasmic reticulum (ER) and transported to the Golgi complex for further modification and proteolytic cleavage into the surface protein (SU) and the transmembrane protein (TM) (15, 23, 32, 36) . The Env protein that is correctly processed and expressed on the cell surface is assembled into the virion. Env on the virion mediates its binding to the host cell surface receptor and thereby triggers the infection (15) . Thus, Env plays a crucial role in both the early and the late stages of retrovirus replication.
Retroviral Env protein is oligomerized in the ER, and its oligomerization is essential for its transport from the ER to the Golgi complex (8, 37) . In proteins which form multimers, some mutants could form abnormal multimers with the wild-type proteins and would disturb normal function as dominant negative mutants (12) . For example, dominant negative Gag mutants of human immunodeficiency virus have previously been reported by Trono et al. (33) . They showed that the mutants suppress the wild-type human immunodeficiency virus production and suggested the development of an antiviral strategy based on intracellular immunization (3) . Because the surface expression of Env could be cytopathogenic, leading to syncytium formation (19, 31 ), a dominant negative mutant which inhibits not only the infectious virus formation but also the surface expression of Env is preferable for the antiviral strategy. Here, we present a dominant negative Env mutant of Friend murine leukemia virus (FMLV) which inhibits the processing and the surface expression of the wild-type Env.
Friend erythroleukemia cells produce FMLV, which is a member of the ecotropic MLV (10, 25) . The initial FMLV env gene product in the ER is an endoglycosidase H (endo H)-sensitive Env precursor, SU-TM, detected as gPr9Oenv. The SU-TM in the ER is transported to the Golgi complex to form an endo H-resistant modified SU-TM which migrates slightly more slowly than the SU-TM in the ER in gel * Corresponding author. electrophoresis (9, 17) . The SU-TM modified in the Golgi complex is rapidly cleaved into SU (gp7O) and TM [p15(E)], which are transported to the cell surface.
We previously obtained a mutant erythroleukemia cell clone, FR-6, by immunoselection with an anti-ecotropic MLV antiserum in the presence of complement (38) . The immunoresistant FR-6 cells express a mutant FMLV Env, which is not proteolytically cleaved, and produce no FMLV. For this paper, we cloned the mutant env gene, analyzed the processing of its product, and examined the effect of its expression on ecotropic Moloney MLV (MoMLV) infection. Interestingly, the mutant Env in the ER trans-dominantly and efficiently interfered with MoMLV infection at two different stages.
MATERIALS AND METHODS
Cells and viruses. 745a is a Friend murine erythroleukemia cell line, which harbors FMLV and spleen focus-forming virus (SFFV) (6, 25) . FR-6 is an immunoselected mutant cell line which survived the complement-dependent cytotoxicity caused by an anti-ecotropic MLV antiserum, anti-FN2 (a-FN2) (38) . NIH 3T3 cells were obtained from Y. Kuchino (National Cancer Research Center). The cells were cultured in Dulbecco's modified minimal essential medium (DMEM) supplemented with 7% fetal bovine serum. MoMLV with an Escherichia coli supF gene in the long terminal repeat (LTR) was provided by R. Jaenisch (Whitehead Institute) (26) . Amphotropic MLV was provided by the late W. P. Rowe.
RT-PCR amplification of env gene fragments. Total cellular RNA was subjected to reverse transcription (RT) and polymerase chain reaction (PCR) amplification as described before (28, 29 Hirt's supernatant and Southern blot analysis. Hirt's supernatant was harvested as described before (13) . Cells were plated at a density of 2 x 106 cells per 10-cm dish, grown overnight, and infected with MoMLV. After incubation for 5 h at 37°C, the cells were swelled with 2 ml of T10E10 (10 mM Tris-HCl, pH 7.5, 10 mM EDTA), with 2 ml of 1.2% sodium dodecyl sulfate (SDS) in T10E10 added, and lysed for 30 min.
One milliliter of 5 M NaCl was added, and the samples were kept overnight at 4°C and centrifuged at 18,000 rpm (Hitachi RP-55T rotor) for 30 min at 4°C. The supernatant was incubated with 0.2 mg of proteinase K per ml for 30 min at 37°C, precipitated by ethanol after phenol-chloroform extraction, and resuspended with TE (10 mM Tris-HCl, pH 8.0, 1 mM EDTA).
The whole Hirt's supernatant from a 10-cm dish was electrophoresed through 0.7% agarose gels, and Southern blot analysis was performed according to the standard procedure (29) . The probe used for hybridization was E-XBO.8, an ecotropic MLV env-specific XbaI-BamHI fragment of MoMLV (nt 5766 to 6537 according to Shinnick's numbering [30] ). The probe was labeled with [a-32P]dCrP by the random-primer method (29) .
Isolation of RNA and Northern (RNA) blot analysis. Total cellular RNA was isolated by the guanidine-hydrochloride method (21) . Ten micrograms of total RNA was electrophoresed through 1% agarose gels containing 6.7% formaldehyde, and Northern blot analysis was performed according to the standard procedure (29) . The probes used for hybridization were rAN7 containing an E. coli supF gene (26) and a human P-actin pseudogene (provided by the late T. Kakunaga), both of which were labeled with [a-32P]dCI P.
Western blot (immunoblot) analysis. Cellular proteins were extracted with RIPA buffer (20 mM Tris-HCl [pH 7.5], 1% Triton X-100, 0.05% SDS, 0.5% sodium deoxycholate, 150 mM NaCl) and were subjected to Western blot analysis (29) . Briefly, the protein samples (20 ,g each) mixed with an equal volume of the sample buffer (125 mM Tris-HCl, pH 6.8, 1% SDS, 10% 2-mercaptoethanol, 20% glycerol, 1% bromophenol blue) were separated through 0.1% SDS-10% polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a Nitroplus 2000 membrane (Micron Separations Inc.) with a Trans-blot (Bio-Rad) at 12 V for 25 min with transfer buffer (25 mM Tris, pH 8.3, 192 mM glycine, 20% methanol). The membrane was incubated in BLOTTO (5% skimmed milk, 50 mM Tris-HCl, pH 8.0) with the polyclonal goat anti-gp7O (SU) antibody (National Cancer Institute lot 79S000713) overnight at room temperature and then was incubated with the peroxidase-conjugated rabbit anti-goat immunoglobulin G antibody (Cappel) for 90 min at room temperature. Immunoreacting proteins were visualized by 0.03% 3-3'-diaminobenzidine-tetrahydrochloride and 0.018% hydrogen peroxide in Tris-buffered saline (20 mM Tris-HCl, pH 8.0, 0.5 M NaCI).
Immunofluorescent staining. Cells grown on a glass slide were fixed with 2% paraformaldehyde in phosphate-buffered saline (PBS). The cells were incubated in BLO1TO with the polyclonal goat anti-gp7O antibody for 60 min at 37°C and then with the fluorescein-conjugated rabbit anti-goat immunoglobulin G antibody (Cappel) for 30 min at 37°C. The glass slide was mounted with 50% glycerol in PBS and inspected under a fluorescence microscope. For permeabilization of cell surface membrane, cells were incubated with 0.1% Triton X-100 in PBS for 5 min at room temperature after fixation.
Immunoprecipitation analysis. Cells . Nucleotide sequencing of the cloned cDNA revealed a transition from T (745a) to C (FR-6) at nt 6960 of the FMLV env gene in FR-6, resulting in a substitution from Cys to Arg at the 361st amino acid (aa) in the FMLV Env (Fig. 1A) . No other nucleotides, including the cleavage junction between SU and TM, were mutated.
To confirm that the Cys-361-to-Arg mutation in the FMLV Env was responsible for the FR-6 phenotype, the cloned FMLV env genes were expressed in NIH 3T3 cells. The cloned env fragments (nt 5391 to 7706) were introduced into FMLV env expression plasmids containing a selection marker, a hygromycin B-resistant gene, to obtain pHmFW (the wild-type FMLV env expression plasmid) and pHmFCr (the Cys-361-mutated FMLV env expression plasmid) ( (Fig. 3A) but not in FCrl cells (Fig. 3C ).
With the detergent treatment, fluorescence with coarse granular staining was found throughout the cytoplasm in 7805 FW1 cells (Fig. 3B) . In FCrl cells, however, fluorescence I I I was localized in the perinuclear space and the granular staining was absent (Fig. 3D) . A pattern similar to the latter was previously reported in the mutant Env with a defect in transport from the ER to the Golgi complex (37) .
The of a 30-min labeling without chase showed that similar amounts of FMLV Env proteins were produced in FW1 and FCrl cells and BFA-treated FW1 cells (Fig. 4A, lanes 1, 2,  and 4) . In BFA-treated FW1 cells, the uncleaved Env proteins in the ER were degraded rapidly, and only about 20% of them were detected after a 6-h chase (Fig. 4C, lanes The change in radioactivity in SU-TM during the pulse-chase period. The radioactivity levels of SU-TMs in panels A, lanes 2 to 4, and C, lanes 2 to 4 and 6 to 8, were counted with an image analyzer.
2 and 6, and 4D). In FCrl cells, however, the Cys-361-mutated Env proteins were retained stably and about 80% of them could still be detected after a 6-h chase (Fig. 4C, lanes  3 and 7, and 4D) . Consequently, the Cys-361-mutated Env accumulated because of its extremely slow degradation.
Furthermore, we compared these results with those of another FMLV Env-processing mutant. The mutant env, represented by fba (Friend BamHI site [nt 6547] deletion mutant), was missing 33 bases from nt 6548 to 6580, corresponding to 11 aa (224 to 234 in SU-TM) (Fig. 1A) . There To elucidate the inhibitory step of the MoMLV production in NIH 3T3-MoMLV/pHmFCr cells, we first examined the viral message. Total cellular RNAs were extracted from NIH 3T3-MoMLV, NIH 3T3-MoMLV/pHmFW, NIH 3T3-MoMLV/pHmFCr, and NIH 3T3-MoMLV/pHmFBa cells. Northern blot analysis with the supF-specific probe, which detects mRNAs only from MoMLV, showed the same amounts of MoMLV mRNAs in these cells (Fig. 6) . The The translation products of MoMLV env were studied by immunoprecipitation analysis with the anti-gp7O antibody (Fig. 7) . MoMLV Env precursor SU-TM, gPr8Oenv, could be discriminated from the transfected FMLV Env SU-TM, gPr9Oenv, by the difference in their electrophoretic mobilities (5) . Similar amounts of MoMLV SU-TMs were detected in NIH 3T3-MoMLV and NIH 3T3-MoMLV/pHmFCr cells labeled for 30 min (Fig. 7A, lanes 1 and 2) . MoMLV env expression was not disturbed at the translational level in NIH 3T3-MoMLV/pHmFCr cells.
The immunoprecipitation analysis after a 30-min chase confirmed that MoMLV Env was cleaved into SU in NIH 3T3-MoMLV cells (Fig. 7A, lane 3) . NIH 3T3-MoMLV/ pHmFW and NIH 3T3-MoMLV/pHmFBa cell lysates also contained SU (Fig. 7A, lanes 5 and 6) . In NIH 3T3-MoMLV/ pHmFCr cells expressing both the wild-type MoMLV and the Cys-361-mutated Env, however, neither SU nor modified SU-TM in the Golgi complex was detected (Fig. 7A, lane 4 ; Fig. 7B, lane 2) . Therefore, the wild-type MoMLV env expression was disturbed at the posttranslational level in NIH 3T3-MoMLV/pHmFCr cells; the Cys-361-mutated Env trans-dominantly inhibited the wild-type Env processing to suppress the MoMLV production.
The 11-aa-deleted Env, however, had no significant effect on the virus production. Thus, Env-processing mutants do not necessarily inhibit MoMLV infection; the trans-dominant inhibition is unique to the Cys-361-mutated Env.
The Cys-361-mutated Env tmns-dominantly inhibits the transport of the wild-type Env from the ER to the Golgi complex. To confirm the dominant negative effect of the Cys-361-mutated Env on the wild-type Env processing in the absence of the other viral genes, a MoMLV env expression plasmid, pNeMoW, containing a neoresistant marker gene was reconstructed (Fig. 1C) The results of immunoprecipitation analysis with the antigp7O antibody of these cell lysates chased for 30 min after 30 min of labeling are shown in Fig. 7C . MoMLV SU-TM was cleaved into SU in NIH 3T3/pNeMoW cells, while it remained uncleaved in FCrl/pNeMoW cells. Furthermore, the wild-type MoMLV SU-TM modified in the Golgi complex was detected in NIH 3T3/pNeMoW lysates but not in FCrl/pNeMoW lysates. Thus, the processing of the wildtype Env in FCrl/pNeMoW cells was disturbed before the SU-TM modification in the Golgi complex.
The subcellular localization of Env protein was then analyzed by immunostaining with the anti-gp7O antibody. NIH 3T3/pNeMoW cells ( Fig. 8A and B) showed the surface expression of Env as FW1 (Fig. 3A and B) , while FCrl/ pNeMoW cells ( Fig. 8C and D) showed the same fluorescence pattern as FCrl cells (Fig. 3C and D) . Therefore, it is confirmed that the intracellular transport of the wild-type MoMLV Env from the ER to the Golgi complex was trans-dominantly inhibited by the Cys-361-mutated Env accumulating in the ER.
DISCUSSION
Proper folding of the retroviral Env protein in the ER is essential for its oligomerization and its transport from the ER to the Golgi complex, and the disulfide bond plays an important role in the folding (2, 4, 7) . The wild-type FMLV Env protein has 20 cysteine residues in SU and is folded correctly with a certain intramolecular disulfide bond pattern in which Cys-361 (the 16th Cys from the N terminal) is disulfide bonded with Cys-373 (the 17th Cys) (20) . Because the Cys-361-to-Arg substitution disrupts this disulfide bond, the Cys-361-mutated Env could not be folded correctly. The slightly slower mobility of the mutant SU-TM than the wild-type SU-TM on SDS-PAGE under nonreducing conditions (Fig. 4B, lane 2) gives experimental support to the above notion.
We showed that the intracellular transport of the Cys-361-mutated Env protein from the ER to the Golgi complex was inhibited. One explanation for this inhibition is that the misfolded mutant Env in the ER fails to form an oligomer essential for its transport. Another explanation is that the mutant Env in the ER forms an abnormal multimer which could not be transported into the Golgi complex. The molecule in FCrl lysates which migrated very slowly on SDS-PAGE under nonreducing conditions (Fig. 4B , lane 2, P) may represent the abnormal multimer, suggesting that the Cys-361-mutated Env aggregates with intermolecular disulfide bonds in the ER.
The cells harboring the Cys-361-mutated Env in the ER were completely resistant to MoMLV infection. The failure of MoMLV infection before the proviral DNA formation must be at the viral penetration, which indicates the ability of the Cys-361-mutated Env to bind to the ecotropic MLV receptors (1, 18) in the ER. It is inferred that the Cys-361-mutated Env traps the ecotropic receptors in the ER, and as a result, the absence of the ecotropic receptors on the cell surface brings about the interference with MoMLV infection. A very weak interference by FMLV SU retained in the ER was previously reported (11) the Cys-361-mutated Env described here is probably due to its accumulation, which may trap almost all of the ecotropic MLV receptors within the ER.
The Cys-361-mutated Env in the ER trans-dominantly inhibited not only the new MoMLV infection but also the production of virus from the established provirus. The suppression of the MoMLV production was caused by the inhibition of the wild-type Env transport from the ER to the Golgi complex. There are two possible mechanisms. First, the mutant Env may consume a factor specific and essential for the retroviral Env transport. Several factors essential for the protein transport, such as BiP, have been reported (2), but no factor specific for retroviral proteins has been described. Second, the Cys-361-mutated Env may bind to the wild-type Env and trap it in the ER; the presence of Env aggregate supports this idea. Probably, the amphotropic Env would not cooligomerize with the ecotropic Env, which may also be the reason that the inhibition by the Cys-361-mutated Env is ecotropic MLV-specific.
For antiviral strategy, one of the problems with dominant negative mutants is the leakiness of the wild-type protein function. The inhibitory effect on virus infection by the Cys-361-mutated Env is exerted at two different stages and reinforced because of its accumulation. Therefore, the Cys-361-mutated Env efficiently interferes with MoMLV infection.
It has been argued that dominant negative human immunodeficiency virus Gag and Rev mutants exert their inhibitory effect via formation of nonfunctional multimers with the mature wild-type proteins (14, 22, 33) . The Cys-361-mutated Env described here is unique in that it inhibits the maturation of the wild-type precursor and precludes the subcellular Env distribution. The surface expression of the wild-type Env, which could be pathogenic by promoting syncytium formation (19, 31) , is inhibited by the mutant Env in the ER.
In conclusion, the Cys-361-mutated Env protein accumulating in the ER efficiently inhibits MoMLV infection at two different stages as a dominant negative mutant (Fig. 9) . First, it traps the ecotropic MLV receptors within the ER. Second, it traps the wild-type MoMLV Env within the ER. These downregulations by protein-protein interactions reinforced DOMINANT NEGATIVE env MUTANT 2033 by protein accumulation may lead to the development of an antiviral strategy.
